Tempus AI (NASDAQ:TEM) Trading Down 8.8% on Insider Selling

Tempus AI, Inc. (NASDAQ:TEM) was down 8.8% during trading on Monday after an insider sold shares in the company. The company traded as low as $43.90 and last traded at $44.79. Approximately 4,426,418 shares were traded during mid-day trading, a decline of 7% from the average daily volume of 4,781,867 shares. The stock had previously closed at $49.10.

Specifically, CEO Eric P. Lefkofsky sold 562,345 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $50.93, for a total transaction of $28,640,230.85. Following the transaction, the chief executive officer now directly owns 9,457,283 shares in the company, valued at approximately $481,659,423.19. This represents a 5.61 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Nadja West sold 809 shares of the stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $51.11, for a total transaction of $41,347.99. Following the transaction, the director now owns 37,705 shares in the company, valued at approximately $1,927,102.55. The trade was a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In related news, COO Ryan Fukushima sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $51.15, for a total value of $1,023,000.00. Following the completion of the sale, the chief operating officer now directly owns 924,460 shares in the company, valued at approximately $47,286,129. The trade was a 2.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. TD Cowen reissued a “buy” rating and set a $74.00 price objective (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. JPMorgan Chase & Co. cut Tempus AI from an “overweight” rating to a “neutral” rating and boosted their target price for the stock from $50.00 to $55.00 in a report on Tuesday, February 25th. Guggenheim restated a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Bank of America increased their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a research report on Monday, March 3rd. Finally, Piper Sandler decreased their price target on shares of Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $61.18.

Tempus AI Stock Up 0.9 %

The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The stock has a 50-day moving average price of $54.52 and a 200-day moving average price of $52.17.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Operose Advisors LLC acquired a new position in shares of Tempus AI in the fourth quarter valued at about $25,000. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI during the 3rd quarter worth approximately $30,000. Farther Finance Advisors LLC bought a new position in shares of Tempus AI during the fourth quarter worth approximately $34,000. Prestige Wealth Management Group LLC grew its position in Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after buying an additional 965 shares in the last quarter. Finally, NewEdge Advisors LLC bought a new position in Tempus AI during the 4th quarter worth $49,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.